NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹3.54 Cr | ₹3.00 Cr | ₹2.79 Cr | ₹2.61 Cr | ₹1.47 Cr |
What is the latest Long Term Provisions ratio of NATH BIOGENES (INDIA) ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹3.54 Cr |
| Mar2024 | ₹3.00 Cr |
| Mar2023 | ₹2.79 Cr |
| Mar2022 | ₹2.61 Cr |
| Mar2013 | ₹1.47 Cr |
How is Long Term Provisions of NATH BIOGENES (INDIA) Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.54 Cr | 18.10 | |
| Mar2024 | ₹3.00 Cr | 7.64 | |
| Mar2023 | ₹2.79 Cr | 6.74 | |
| Mar2022 | ₹2.61 Cr | 77.74 | |
| Mar2013 | ₹1.47 Cr | - | |
Compare Long Term Provisions of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹265.4 Cr | 2.8% | -6.8% | -10.8% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹9,842.7 Cr | -0.5% | -16.8% | -18.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,307.8 Cr | 3.8% | 8.6% | -36% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,723.9 Cr | -3% | -9.2% | -24.6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹917.2 Cr | 18.4% | -2.7% | -41.4% | Stock Analytics | |
| INDO US BIOTECH | ₹208.9 Cr | 1.8% | -26.6% | -40.4% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 2.8% |
-6.8% |
-10.8% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses